The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma

Author：          

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.2, 2013-01, pp. : 669-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

By Ma Xiao-Juan   Huang Rui   Kuang An-Ren  

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene

By        

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1666-1670

Spandidos Publications

Access to resources Recommend Favorite

131I therapy mediated by sodium/iodide symporter combined with kringle 5 has a synergistic therapeutic effect on glioma

By                

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 691-698

Spandidos Publications

Access to resources Recommend Favorite

Radiofrequency induction on sodium/iodide symporter expression of thyroid cancer

By Tian Youxin   Liu Qinjiang   Ni Yaqiong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 516-520

Springer Publishing Company

Access to resources Recommend Favorite